Closing Bell: Nervgen Pharma Corp down on Monday (NGEN)

Today, Nervgen Pharma Corp shares opened at $2.84 and closed at $2.80. It traded at a low of $2.80 to a high of $2.95.

Share prices decreased -1.93 percent from the previous day's close of $2.85.

Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 36,381 on 90 total trades. On average, Nervgen Pharma Corp has traded 52,643 shares over 5 days and 87,142 year-to-date.

Trading across the entire TSX-V saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 72.84 percent, while this year, they have raised 3.70%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $199.64 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..